Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Relevance Between the microRNA-30e in Plasma and the Prognosis of Schizophrenia Patients

NCT03007303 is registered in ClinicalTrials.gov with Dalian Seventh People's Hospital as lead sponsor.

NCT NCT03007303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03007303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Relevance Between the microRNA-30e in Plasma and the Prognosis of Schizophrenia Patients
Lead sponsor
Dalian Seventh People's Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2016
Completion date
July 31, 2020
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

micrognathia, schizophrenia